CYCLO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
CYCLO THERAPEUTICS, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $3.68 per share as of 2023-12-31, per its 10-K/A filed 2024-12-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2024-12-18
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.68.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.81.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $7.44.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $7.44.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | $3.68 10-K/A · filed 2024-12-18 |
| 2022-12-31 | $5.81 10-K · filed 2023-03-17 |
| 2021-12-31 | $7.44 10-K · filed 2022-03-11 |
| 2021-09-30 | $7.44 10-Q · filed 2021-11-15 |